INSIGHTS ON PHARMACEUTICAL INSPECTION

• Visual Inspection Equipment To Deliver The Highest Product Integrity

  Gain insight into an advanced inspection solution for pharmaceuticals that ensures drug integrity and reduces costs with flexible technologies, from lab development to high-volume production.

• Start Packaging Development Early

  To avoid costly delays later in the product lifecycle, it is essential to plan for key variables early and select container closure systems with confidence from the outset.

• USP <788> Revisions And Why Packaging Matters More Than Ever

  Prepare for the upcoming USP <788> revisions by strengthening your particulate control strategy to support regulatory compliance, product quality, and patient safety across injectable drug products.

• Integrity Testing Of Inhaler Products

  Ensuring inhaler integrity is vital for patient safety and regulatory compliance. Discover how Vacuum decay testing provides a sensitive, non-destructive method to detect leaks and maintain sterility.

• EU And PIC/S Annex 1: CCS Shortfalls After 2 Years Of Implementation

  4/16/2026

  Explore how to elevate Contamination Control Strategies from static documents to inspection-ready, lifecycle tools, as well as practical approaches to Annex 1 compliance and risk-based CCS development.

• OEE And Product Inspection

  2/13/2025

  Explore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.

• Understanding Injectable Drug Container Closure Systems

  6/20/2024

  Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.

• What Is The Position Of Regulatory Authorities On PUPSIT?

  5/2/2025

  PUPSIT and other integrity testing methods are crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines.

• Visual Inspection Of Advanced Therapy Medicinal Products

  9/2/2025

  Discover how expert database systems for inspection defect management and control help cell and gene therapies meet the requirements of USP-790 to assure they are essentially free from particulate matter.